Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Addison's disease.

Lynnette K Nieman1, Maria L Chanco Turner

  • 1Reproductive and Biology Medicine Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA. niemanl@nih.gov

Clinics in Dermatology
|July 11, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aligning treatment to physiology: when to use chronotherapy, block and replace, or titration to treat hypercortisolism.

Journal of the Endocrine Society·2026
Same author

Artificial Intelligence-Based Approach for Automated Gonad Volume Quantification Using Magnetic Resonance Imaging in Healthy Adolescents Across Puberty.

Diagnostics (Basel, Switzerland)·2026
Same author

The interplay between loneliness, cortisol, and NK cell function: The role of cortisol in NK cell dysfunction.

Psychoneuroendocrinology·2026
Same author

Phosphoproteomic dysregulation drives tumor proliferation in Cushing's disease.

bioRxiv : the preprint server for biology·2025
Same author

Unmasking Hypercortisolism in Difficult-to-Control Type 2 Diabetes: A Useful Paradigm Shift?

Diabetes care·2025
Same author

Diagnosis of Cushing's Disease.

Endocrinology and metabolism clinics of North America·2025
Same journal

Letter to the editor in reply to "Ethics of Rising Trends in Dermatology Publications Using Large-Scale Databases".

Clinics in dermatology·2026
Same journal

Ethics of suggesting image-guided superficial radiation therapy on the pathology report.

Clinics in dermatology·2026
Same journal

Tanorexia: The Psychodermatology of Compulsive Tanning.

Clinics in dermatology·2026
Same journal

Ear manifestations of connective tissue diseases: A dermatologic, histopathologic, and clinicopathologic review.

Clinics in dermatology·2026
Same journal

Discovery of an intravenous drug injection site: A meticulous cutaneous examination provides the forensic dermatologic clue to a diagnosis of homicide.

Clinics in dermatology·2026
Same journal

Sherlock Holmes and the mystery of the deadly diet.

Clinics in dermatology·2026
See all related articles

Addison's disease, or primary adrenal insufficiency, causes hormone deficiencies. Diagnosis involves specific tests, and treatment requires hormone replacement therapy for managing symptoms like skin darkening and fatigue.

Area of Science:

  • Endocrinology
  • Internal Medicine

Background:

  • Addison's disease, or primary adrenal insufficiency, is characterized by glucocorticoid and mineralocorticoid deficiency.
  • Symptoms range from acute adrenal crisis (hypotension, fever, hypoglycemia) to chronic insidious onset (malaise, anorexia, weight loss, pain).
  • Distinctive cutaneous manifestations include skin darkening and hyperpigmentation in specific areas.

Purpose of the Study:

  • To summarize the key aspects of Addison's disease, including its presentation, diagnosis, and management.
  • To highlight the diagnostic challenges and effective testing methods for primary adrenal insufficiency.

Main Methods:

  • Review of clinical presentation, including acute and chronic symptoms.
  • Description of characteristic cutaneous manifestations.

Related Experiment Videos

  • Evaluation of diagnostic approaches, noting the insensitivity of basal plasma cortisol measurements.
  • Highlighting the efficacy of the synthetic adrenocorticotropin 1-24 stimulation test.
  • Mentioning confirmation through elevated plasma adrenocorticotropin and renin levels.

    • Main Results:

    • Basal plasma cortisol measurement is an insensitive screening test for Addison's disease.
    • The synthetic adrenocorticotropin 1-24 (250 microg) dynamic test is effective for diagnosis.
    • Elevated plasma adrenocorticotropin and renin levels confirm primary adrenal insufficiency.

    Conclusions:

    • Addison's disease requires hormone replacement therapy for deficient glucocorticoids and mineralocorticoids.
    • Accurate diagnosis relies on dynamic testing and biochemical markers, not solely basal cortisol levels.
    • Understanding the diverse clinical and cutaneous manifestations is crucial for timely diagnosis and management.